当前位置: 首页 > 期刊 > 《中华中西医杂志》 > 2005年第1期
编号:10578705
P16,BCL-2在大肠癌中表达的研究
http://www.100md.com 《中华中西医杂志》 2005年第1期
免疫组化,大肠癌,P16,BCL-2,免疫组化,1材料与方法,2结果,3讨论,4结论,参考文献
     【摘要】 目的 P16和BCL—2在53例在肠癌中的表达,了解该基因与大肠癌生物学行为的关系。 方法 采用LABC免疫组化方法观察,P16基因,BCL—2基因产物在53例大肠癌组织中的表达情况。 结果 53例大肠癌中,P16阳性34例,BCL—2阳性33例,且P16随分化程度降低,阳性率降低,高分化与低分化癌差别有显著意义。BCL—2随分化程度降低而阳性率升高,低分化癌与高分化癌及粘液癌差别有显著意义。 结论 本研究表明P16,BCL—2表达与大肠癌的分化程度相关。

    【关键词】 大肠癌 P16 BCL-2 免疫组化

    The study on expressions of P16,BCL-2genes in colorectal carcinoma

    Kang Xiaoxu

    NO.4People's Hospital of Panjin,Liaoning,124000.

    【Abstract】 Objective To examine the expressions of P16and BCL-2genes in53cases of colorectal carci-noma determined the relationship between the genes and colorectal carcinoma.Methods The expression of P16and BCL-2in53cases colorectal carcinoma was detected by SABC immunohistochemical method.Results In53cases colorectal carcinoma,P16was positive in34and BCL-2was33.The P16positive rates were significantly lower in poorly differentiated.Expressions of P16in well differentiated colorectal carcinoma were significantly different from poorly.The BCL-2positive rates were significantly higher.In poorly differentiated,expressions of BCL-2in well or mucus colorectal carcinoma were significantly different from poorly differentiated colorectal carcinomas.Conclusion Our results showed that the expression of P16and BCL-2was closely related to differentiation. ......

您现在查看是摘要页,全文长 10573 字符